Lihua E. Budde
Impact in
- Oncology top 0.5%
- CAR-T cell therapy research
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 116
- CAR-T cell therapy research 101
- Cancer Immunotherapy and Biomarkers 10
-
- Lymphoma Diagnosis and Treatment 74
- Co-authors
- Stephen J. Forman (45 shared papers)Nancy L. Bartlett (36 shared papers)Michael C. Jensen (9 shared papers)Oliver W. Press (15 shared papers)Brian G. Till (11 shared papers)Xiuli Wang (14 shared papers)Stanley R. Riddell (6 shared papers)Jinjuan Wang (4 shared papers)
- Journals
- Blood (67 papers)Journal of Clinical Oncology (18 papers)Blood Advances (6 papers)Hematological Oncology (5 papers)British Journal of Haematology (4 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Lihua E. Budde
140 papers receiving 3.5k citations
Lihua E. Budde's Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 2.9k
- Pathology and Forensic Medicine 1.0k
- Immunology 843
- Genetics 337
- Hematology 237
Countries citing papers authored by Lihua E. Budde
This map shows the geographic impact of Lihua E. Budde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihua E. Budde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihua E. Budde more than expected).
Fields of papers citing papers by Lihua E. Budde
This network shows the impact of papers produced by Lihua E. Budde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihua E. Budde. The network helps show where Lihua E. Budde may publish in the future.
Co-authors
The 25 scholars most cited alongside Lihua E. Budde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma Hit paper breakdown → | 2017 | 474 |
| 2 | CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results Hit paper breakdown → | 2012 | 435 |
| 3 | 2013 | 307 | |
| 4 | Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study Hit paper breakdown → | 2022 | 275 |
| 5 | 2013 | 162 | |
| 6 | 2019 | 145 | |
| 7 | 2017 | 139 | |
| 8 | 2017 | 85 | |
| 9 | 2021 | 70 | |
| 10 | 2015 | 52 | |
| 11 | 2017 | 49 | |
| 12 | 2011 | 49 | |
| 13 | 2023 | 46 | |
| 14 | 2024 | 45 | |
| 15 | 2018 | 44 | |
| 16 | 2015 | 43 | |
| 17 | 2020 | 42 | |
| 18 | 2017 | 39 | |
| 19 | 2021 | 33 | |
| 20 | 2022 | 32 |
About Lihua E. Budde
Lihua E. Budde is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 154 papers that have together received 3.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (101 papers), Lymphoma Diagnosis and Treatment (74 papers), Chronic Lymphocytic Leukemia Research (26 papers), Monoclonal and Polyclonal Antibodies Research (23 papers), Immune Cell Function and Interaction (13 papers), Biosimilars and Bioanalytical Methods (11 papers), Cutaneous lymphoproliferative disorders research (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Oncology (2.9k citations), Pathology and Forensic Medicine (1.0k citations), Immunology (843 citations), Genetics (337 citations) and Hematology (237 citations). Lihua E. Budde has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Stephen J. Forman, Nancy L. Bartlett, Michael C. Jensen, Oliver W. Press, Brian G. Till, Xiuli Wang, Stanley R. Riddell, Jinjuan Wang, Yukang Lin and Tanya Siddiqi. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Hematological Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.